Merck (Germany) Top Insiders
| MRK Stock | EUR 151.90 2.05 1.37% |
Merck employs about 63.7 K people. The company is managed by 52 executives with a total tenure of roughly 462 years, averaging almost 8.0 years of service per executive, having 1225.44 employees per reported executive. Examination of Merck's management performance can provide insight into the company performance.
| Kenneth Frazier Chairman Chairman of the Board, President, Chief Executive Officer |
| Michael Rosenblatt President Executive Vice President Chief Medical Officer |
Merck |
Merck Management Team Effectiveness
The company has return on total asset (ROA) of 0.0656 % which means that it generated a profit of $0.0656 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1422 %, meaning that it generated $0.1422 on every $100 dollars invested by stockholders. Merck's management efficiency ratios could be used to measure how well Merck manages its routine affairs as well as how well it operates its assets and liabilities.Merck Workforce Comparison
Merck Company is considered to be number one stock in number of employees category among related companies. The total workforce of Drug Manufacturers—Specialty & Generic industry is now estimated at about 65,769. Merck totals roughly 63,723 in number of employees claiming about 97% of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of 0.16 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.23 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.23. Merck Company Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Merck Company Price Series Summation is a cross summation of Merck price series and its benchmark/peer.
Merck Notable Stakeholders
A Merck stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Merck often face trade-offs trying to please all of them. Merck's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Merck's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Kenneth Frazier | Chairman of the Board, President, Chief Executive Officer | Profile | |
| Michael Rosenblatt | Executive Vice President Chief Medical Officer | Profile | |
| Mirian GraddickWeir | Executive Vice President - Human Resources | Profile | |
| Julie Gerberding | Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy and Population Health | Profile | |
| Robert Davis | Executive Vice President, Global Services, Chief Financial Officer | Profile | |
| Steven Mizell | Executive Vice President, Chief Human Resources Officer, Human Resources | Profile | |
| Jim Scholefield | Executive Vice President, Chief Information and Digital Officer | Profile | |
| Sanat Chattopadhyay | Executive Vice President and President - Merck Manufacturing Division | Profile | |
| Adam Schechter | Executive Vice President and Presidentident - Global Human Health | Profile | |
| Jennifer Zachary | Executive Vice President, General Counsel, Corporate Secretary | Profile | |
| Michael Holston | Executive Vice President Chief Ethics and Compliance Officer | Profile | |
| Adele Ambrose | Senior Vice President Chief Communications Officer | Profile | |
| Willie Deese | Executive Vice President and Presidentident - Merck Manufacturing Division | Profile | |
| Rita Karachun | Senior Vice President - Finance, Global Controller | Profile | |
| Michael Nally | Executive Vice President, Chief Marketing Officer | Profile | |
| Clark Golestani | Executive Vice President CIO | Profile | |
| Roger Perlmutter | Executive Vice President and Presidentident - Merck Research Laboratories | Profile | |
| Ashley Watson | Senior Vice President Chief Ethics and Compliance Officer | Profile | |
| Richard DeLuca | Executive Vice President and Presidentident - Merck Animal Health | Profile | |
| Frank Clyburn | Executive Vice President, Chief Commercial Officer | Profile | |
| Rochelle Lazarus | Independent Director | Profile | |
| Paul Rothman | Independent Director | Profile | |
| Mary Coe | Independent Director | Profile | |
| Patricia Russo | Independent Director | Profile | |
| Robert Kidder | Independent Director | Profile | |
| Thomas Cech | Independent Director | Profile | |
| William Harrison | Lead Independent Director | Profile | |
| Thomas Glocer | Independent Director | Profile | |
| Craig Thompson | Independent Director | Profile | |
| Christine Seidman | Independent Director | Profile | |
| Wendell Weeks | Independent Director | Profile | |
| Kathy Warden | Independent Director | Profile | |
| Peter Wendell | Independent Director | Profile | |
| John Noseworthy | Independent Director | Profile | |
| Leslie Brun | Lead Independent Director | Profile | |
| Inge Thulin | Independent Director | Profile | |
| Pamela Craig | Independent Director | Profile | |
| Carlos Represas | Independent Director | Profile | |
| Gerhard Schmitz | Head Accounting | Profile | |
| Michael Fleming | Senior Vice President Chief Ethics and Compliance Officer | Profile | |
| Marcus Kuhnert | CFO Board | Profile | |
| Friederike Rotsch | Group Compliance | Profile | |
| Franklin Clyburn | Executive Vice President Chief Commercial Officer | Profile | |
| Matthias Heinzel | CEO Board | Profile | |
| Constantin Fest | Head Relations | Profile | |
| Peter Guenter | CEO Board | Profile | |
| Barbara Weiland | Chief Officer | Profile | |
| Belen MD | Chair CEO | Profile | |
| Joseph Romanelli | IR Contact Officer | Profile | |
| Dirk Toepfer | Chief Officer | Profile | |
| Dean Li | Executive Vice President and Presidentident, Merck Research Laboratories | Profile | |
| Kai Beckmann | CEO Board | Profile |
About Merck Management Performance
The success or failure of an entity such as Merck Company often depends on how effective the management is. Merck management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Merck management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Merck management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. MERCK Kommanditgesellschaft auf Aktien operates as a subsidiary of E. MERCK KGAA operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 57850 people.
The data published in Merck's official financial statements usually reflect Merck's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Merck Company. For example, before you start analyzing numbers published by Merck accountants, it's critical to develop an understanding of what Merck's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Merck's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Merck's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Merck's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Merck Company. Please utilize our Beneish M Score to check the likelihood of Merck's management manipulating its earnings.
Merck Workforce Analysis
Traditionally, organizations such as Merck use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Merck within its industry.Merck Manpower Efficiency
Return on Merck Manpower
| Revenue Per Employee | 308.9K | |
| Revenue Per Executive | 378.6M | |
| Net Income Per Employee | 47.9K | |
| Net Income Per Executive | 58.8M |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Complementary Tools for Merck Stock analysis
When running Merck's price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |